Fjarde Ap Fonden Pfizer Inc Transaction History

Fjarde Ap Fonden

$9.04 Billion
Q1 2024

A detailed history of Fjarde Ap Fonden transactions in Pfizer Inc stock. As of the latest transaction made, Fjarde Ap Fonden holds 1,595,571 shares of PFE stock, worth $44.7 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

1,595,571

Previous 1,565,871 1.9%

Holding current value

$44.7 Million

Previous $45.1 Million 1.78%

% of portfolio

0.49%

Previous 0.56%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$25.89 - $29.73 $768,933 - $882,981	29,700 Added 1.9%	1,595,571 $44.3 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $2.66 Million - $3.45 Million	-101,743 Reduced 6.1%	1,565,871 $45.1 Million
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $1.09 Million - $1.27 Million	-33,900 Reduced 1.99%	1,667,614 $55.3 Million
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $1.07 Million - $1.23 Million	29,500 Added 1.76%	1,701,514 $62.4 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $957,177 - $1.25 Million	-24,300 Reduced 1.43%	1,672,014 $68.2 Million

Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $4.49 Million - $5.87 Million	-107,664 Reduced 5.97%	1,696,314 $87 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $18.2 Million - $21.6 Million	392,200 Added 27.78%	1,803,978 $94.6 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $3.83 Million - $4.74 Million	-83,699 Reduced 5.6%	1,411,778 $73.1 Million
Q4 2021 Feb 15, 2022	SELL	$41.32 - $61.25 $3.84 Million - $5.69 Million	-92,934 Reduced 5.85%	1,495,477 $88.3 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $910,600 - $1.17 Million	-23,200 Reduced 1.44%	1,588,411 $68.3 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $3.08 Million - $3.49 Million	-85,900 Reduced 5.06%	1,611,611 $63.1 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $944,418 - $1.07 Million	28,200 Added 1.69%	1,697,511 $61.5 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $555,602 - $706,496	-16,600 Reduced 0.98%	1,669,311 $61.4 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $1.88 Million - $2.2 Million	59,100 Added 3.63%	1,685,911 $61.9 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $2.46 Million - $2.99 Million	81,800 Added 5.29%	1,626,811 $53.2 Million
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $1.83 Million - $2.62 Million	-67,800 Reduced 4.2%	1,545,011 $50.4 Million
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $1.38 Million - $1.57 Million	-41,900 Reduced 2.53%	1,612,811 $63.2 Million
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $576,827 - $747,976	-17,754 Reduced 1.06%	1,654,711 $59.5 Million
Q2 2019 Jul 17, 2019	SELL	$36.98 - $41.52 $4.81 Million - $5.4 Million	-130,100 Reduced 7.22%	1,672,465 $72.5 Million
Q1 2019 Apr 29, 2019	BUY	$37.5 - $41.2 $13.5 Million - $14.8 Million	360,191 Added 24.97%	1,802,565 $76.6 Million
Q4 2018 Jan 31, 2019	SELL	$38.47 - $43.86 $4.13 Million - $4.71 Million	-107,300 Reduced 6.92%	1,442,374 $63 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $3.55 Million - $4.3 Million	-102,847 Reduced 6.22%	1,549,674 $68.3 Million
Q2 2018 Jul 12, 2018	SELL	$32.98 - $35.16 $1.63 Million - $1.74 Million	-49,569 Reduced 2.91%	1,652,521 $60 Million
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $517,229 - $600,057	16,209 Added 0.96%	1,702,090 $60.4 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $8.61 Million - $9.14 Million	258,882 Added 18.14%	1,685,881 $61.1 Million
Q3 2017 Nov 07, 2017	BUY	$31.0 - $34.15 $1.51 Million - $1.66 Million	48,749 Added 3.54%	1,426,999 $50.9 Million
Q2 2017 Aug 08, 2017	BUY	N/A	1,378,250	1,378,250 $46.3 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account